Welcome, attendees, participants, and organizing committee

We are gathered to discuss Diabetes: its causes, implications, and treatments at the "2^nd Annual International Diabetes 2023" meeting. My interest is in Type II Diabetes.There appears to be 3 primary ways we can influence blood glucose concentrations. They are decreased absorption of carbohydrate in the small intestine, decreased hepatic glucose output, and increased tissue glucose uptake; 80 percent of tissue uptake in presence of insulin is in skeletal muscle.  Each of these or a combination will lower the blood glucose concentration and the complications that arise from chronically elevated blood glucose concentrations.This then, should be the focus of interventions to treat high blood glucose ie. Type II Diabetes. Decreasing the rate of appearenbce in the blood sometimes called glucose Ra and increasing glucose disappearance from the blood sometimes called glucose Rd will lower the concentration of glucose in the blood. Decreased absorption of glucose and other carbohydrates in the small intestine will increase the passing of glucose and other carbohydrates in the feces and therefore lower blood glucose rate of appearance in the circulating blood. Reduced hepatic glucose output will also reduce the glucose Ra in blood. Increasing tissue uptake of glucose or glucose Rd will also lower the concentration of glucose in the blood.Therefore since these appear to be the 3 avenues to lower blood glucose. Interventions such as medicines, exercise, and weight loss, and their combination, should target these physiological processes. With this said, I cordially invite you to participate in the 2^nd annual International Diabetes 2023 Conference by way of presentation and question and answers. As they say in Indianapolis: ”ladies and gentlemen start your engines”. 

Dear congress visitors

It is an honor and pleasure to invite you to participate to the “2nd Edition of the International Conference on Diabetes, Metabolism and Endocrinology” (Diabetes 2023) that will take place on the 16-18 October 2023, in Boston, Massachusetts, USA. During the conference we will explore the latest developments in basic, translational and clinical research related to Diabetes. One of the crucial aspects of this congress is the high-level of interdisciplinary exchange between clinicians and basic researchers with the aim to improve the clinical guidelines for diagnosis and treatment of dysmetabolic diseases and diabetes. We are convinced that to present and discuss each own work with other colleagues, sparking and sharing ideas between scientists, is the key to progress in science. We do encourage you to join us to ask questions and share knowledge during all scientific sessions.

Honourable guests, collaborators and respected speakers

It’s a great pleasure to welcome you all to The 2nd Edition of International Conference on Diabetes, Metabolism and Endocrinology during October 16-18, 2023 in Boston, Massachusetts, USA. We are grateful to the members of the organizing committee who have arranged such a beautiful event.

I wholeheartedly welcome all the delegates from various countries. As you all know, we have seen the rapid increment in the prevalence of diabetes and the challenges in improving the healthcare system. Thus,  we all have gathered to discuss the theme of Hitting Diabetes at the Sweet Spot: Recent Advancements and Innovations and mission to promote awareness and enhance research aiming in developing solutions for the challenges encountered.

The speakers in the programme are uniquely placed to debate, discuss and highlight the key points and enhance research and innovation in developing solutions for the challenges encountered. I thank the Magnus Group LLC, collaborators and speakers, for giving us a platform to raise the issues, collaborate and go through the solutions to such a burning issue.

Thank you and have a pleasant conference!